Barclays
AMED

Barclays’s Amedisys AMED Stock Holding History

Barclays’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,600
Closed -$1.95M – 5519
2020
Q1 		$1.95M Buy
10,600
+800
+8% +$142K ﹤0.01% 2313
2019
Q4 		$1.64M Sell
9,800
-200
-2% -$29.7K ﹤0.01% 3202
2019
Q3 		$1.31M Buy
+10,000
New +$1.3M ﹤0.01% 3385
2019
Q2 		– Sell
-800
Closed -$99K – 6911
2019
Q1 		$99K Sell
800
-8,000
-91% -$1M ﹤0.01% 5365
2018
Q4 		$1.03M Buy
8,800
+7,100
+418% +$837K ﹤0.01% 3077
2018
Q3 		$212K Buy
1,700
+700
+70% +$77.3K ﹤0.01% 4955
2018
Q2 		$85K Sell
1,000
-11,500
-92% -$844K ﹤0.01% 5344
2018
Q1 		$754K Buy
12,500
+3,500
+39% +$199K ﹤0.01% 3542
2017
Q4 		$474K Buy
9,000
+6,800
+309% +$358K ﹤0.01% 3888
2017
Q3 		$123K Buy
2,200
+1,200
+120% +$63.5K ﹤0.01% 4783
2017
Q2 		$63K Buy
1,000
+900
+900% +$52.4K ﹤0.01% 5214
2017
Q1 		$5K Sell
100
-23,600
-100% -$1.13M ﹤0.01% 6262
2016
Q4 		$1.01M Buy
+23,700
New +$1.01M ﹤0.01% 2739
2016
Q3 		– Sell
-200
Closed -$10K – 6580
2016
Q2 		$10K Sell
200
-11,000
-98% -$555K ﹤0.01% 5524
2016
Q1 		$538K Sell
11,200
-10,000
-47% -$386K ﹤0.01% 3092
2015
Q4 		$827K Buy
21,200
+9,700
+84% +$388K ﹤0.01% 2774
2015
Q3 		$426K Buy
11,500
+3,300
+40% +$139K ﹤0.01% 3493
2015
Q2 		$320K Sell
8,200
-400
-5% -$12.5K ﹤0.01% 3814
2015
Q1 		$224K Buy
8,600
+600
+8% +$16.9K ﹤0.01% 4256
2014
Q4 		$232K Sell
8,000
-3,700
-32% -$91.4K ﹤0.01% 4521
2014
Q3 		$234K Sell
11,700
-2,900
-20% -$56K ﹤0.01% 4602
2014
Q2 		$234K Buy
14,600
+7,600
+109% +$108K ﹤0.01% 4675
2014
Q1 		$98K Buy
7,000
+1,900
+37% +$29.2K ﹤0.01% 5469
2013
Q4 		$71K Sell
5,100
-39,500
-89% -$636K ﹤0.01% 5927
2013
Q3 		$758K Buy
44,600
+32,600
+272% +$484K ﹤0.01% 3657
2013
Q2 		$139K Buy
+12,000
New +$137K ﹤0.01% 5520

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Barclays's AMED Position: Q3 2025 in Review

Barclays sold out of Amedisys (AMED) in Q3 2025, closing a stake of 14,221 shares — an estimated $1.4M sold.

Barclays first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $11.9M in Q3 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Barclays reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Barclays sold 14,221 Amedisys shares in Q3 2025, an estimated $1.4M.
  • Barclays first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Barclays's Amedisys position peaked at $11.9M in Q3 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.